Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 von Demaria, Olivier, Carvelli, Julien, Batista, Luciana, Thibult, Marie-Laure, Morel, Ariane, André, Pascale, Morel, Yannis, Vély, Frederic, Vivier, Eric

Volltext

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity von Mamessier, Emilie, Sylvain, Aude, Thibult, Marie-Laure, Houvenaeghel, Gilles, Jacquemier, Jocelyne, Castellano, Rémy, Gonçalves, Anthony, André, Pascale, Romagné, François, Thibault, Gilles, Viens, Patrice, Birnbaum, Daniel, Bertucci, François, Moretta, Alessandro, Olive, Daniel

Volltext

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells von André, Pascale, Denis, Caroline, Soulas, Caroline, Bourbon-Caillet, Clarisse, Lopez, Julie, Arnoux, Thomas, Bléry, Mathieu, Bonnafous, Cécile, Gauthier, Laurent, Morel, Ariane, Rossi, Benjamin, Remark, Romain, Breso, Violette, Bonnet, Elodie, Habif, Guillaume, Guia, Sophie, Lalanne, Ana Ines, Hoffmann, Caroline, Lantz, Olivier, Fayette, Jérôme, Boyer-Chammard, Agnès, Zerbib, Robert, Dodion, Pierre, Ghadially, Hormas, Jure-Kunkel, Maria, Morel, Yannis, Herbst, Ronald, Narni-Mancinelli, Emilie, Cohen, Roger B., Vivier, Eric

Volltext

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells von Ruggeri, Loredana, Urbani, Elena, André, Pascale, Mancusi, Antonella, Tosti, Antonella, Topini, Fabiana, Bléry, Mathieu, Animobono, Lucia, Romagné, François, Wagtmann, Nicolai, Velardi, Andrea

Volltext

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines von van Montfoort, Nadine, Borst, Linda, Korrer, Michael J., Sluijter, Marjolein, Marijt, Koen A., Santegoets, Saskia J., van Ham, Vanessa J., Ehsan, Ilina, Charoentong, Pornpimol, André, Pascale, Wagtmann, Nicolai, Welters, Marij J.P., Kim, Young J., Piersma, Sytse J., van der Burg, Sjoerd H., van Hall, Thorbald

Volltext

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma von PLATONOVA, Sophia, CHERFILS-VICINI, Julien, FRIDMAN, Wolf-Herman, SAUTES-FRIDMAN, Catherine, CREMER, Isabelle, DAMOTTE, Diane, CROZET, Lucile, VIEILLARD, Vincent, VALIDIRE, Pierre, ANDRE, Pascale, DIEU-NOSJEAN, Marie-Caroline, ALIFANO, Marco, REGNARD, Jean-François

Volltext

Roles, responsibilities and characteristics of lay community health workers involved in diabetes prevention programmes: A systematic review von Hill, Jillian, Peer, Nasheeta, Oldenburg, Brian, Kengne, Andre Pascale

Volltext

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission von Vey, Norbert, Bourhis, Jean-Henri, Boissel, Nicolas, Bordessoule, Dominique, Prebet, Thomas, Charbonnier, Aude, Etienne, Anne, Andre, Pascale, Romagne, François, Benson, Don, Dombret, Herve, Olive, Daniel

Volltext

Human NK Cell Education by Inhibitory Receptors for MHC Class I von Anfossi, Nicolas, André, Pascale, Guia, Sophie, Falk, Christine S., Roetynck, Sophie, Stewart, C. Andrew, Breso, Violette, Frassati, Coralie, Reviron, Denis, Middleton, Derek, Romagné, François, Ugolini, Sophie, Vivier, Eric

Volltext

CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer von Magagna, Ilaria, Gourdin, Nicolas, Kieffer, Yann, Licaj, Monika, Mhaidly, Rana, Andre, Pascale, Morel, Ariane, Vincent-Salomon, Anne, Paturel, Carine, Mechta-Grigoriou, Fatima

Volltext

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 von Walzer, Thierry, Bléry, Mathieu, Chaix, Julie, Fuseri, Nicolas, Chasson, Lionel, Robbins, Scott H, Jaeger, Sébastien, André, Pascale, Gauthier, Laurent, Daniel, Laurent, Chemin, Karine, Morel, Yannis, Dalod, Marc, Imbert, Jean, Pierres, Michel, Moretta, Alessandro, Romagné, François, Vivier, Eric

Volltext

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect von Benson, Don M., Bakan, Courtney E., Zhang, Shuhong, Collins, Shauna M., Liang, Jing, Srivastava, Shivani, Hofmeister, Craig C., Efebera, Yvonne, Andre, Pascale, Romagne, Francois, Bléry, Mathieu, Bonnafous, Cécile, Zhang, Jianying, Clever, David, Caligiuri, Michael A., Farag, Sherif S.

Volltext

Targeting natural killer cells in solid tumors von Habif, Guillaume, Crinier, Adeline, André, Pascale, Vivier, Eric, Narni-Mancinelli, Emilie

Volltext

Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors von Hwang, Michael, Fan, Chunling, Yue, Mun Sang, Zhou, Diansong, Paturel, Carine, Andre, Pascale, Cheng, Lin‐Yang, Mitchell, Patrick, Kourtesis, Panagiotis, Ruscica, Dario, Das, Mayukh, Morsli, Nassim, Ren, Song, Gibbs, Megan, Phipps, Alex, Song, Xuyang

Volltext

Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide von Nijhof, Inger S, Lammerts van Bueren, Jeroen J, van Kessel, Berris, Andre, Pascale, Morel, Yannis, Lokhorst, Henk M, van de Donk, Niels W C J, Parren, Paul W H I, Mutis, Tuna

Volltext

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo von Sola, Caroline, André, Pascale, Lemmers, Céline, Fuseri, Nicolas, Bonnafous, Cécile, Bléry, Mathieu, Wagtmann, Nicolai R, Romagné, François, Vivier, Eric, Ugolini, Sophie

Volltext

Monalizumab: inhibiting the novel immune checkpoint NKG2A von van Hall, Thorbald, André, Pascale, Horowitz, Amir, Ruan, Dan Fu, Borst, Linda, Zerbib, Robert, Narni-Mancinelli, Emilie, van der Burg, Sjoerd H., Vivier, Eric

Volltext

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies von Kohrt, Holbrook E., Thielens, Ariane, Marabelle, Aurelien, Sagiv-Barfi, Idit, Sola, Caroline, Chanuc, Fabien, Fuseri, Nicolas, Bonnafous, Cécile, Czerwinski, Debra, Rajapaksa, Amanda, Waller, Erin, Ugolini, Sophie, Vivier, Eric, Romagné, François, Levy, Ronald, Bléry, Mathieu, André, Pascale

Volltext

Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells von Romagné, Francois, André, Pascale, Spee, Pieter, Zahn, Stefan, Anfossi, Nicolas, Gauthier, Laurent, Capanni, Marusca, Ruggeri, Loredana, Benson, Don M., Blaser, Bradley W., Della Chiesa, Mariella, Moretta, Alessandro, Vivier, Eric, Caligiuri, Michael A., Velardi, Andrea, Wagtmann, Nicolai

Volltext

Modification of P-Selectin Glycoprotein Ligand-1 with a Natural Killer Cell-Restricted Sulfated Lactosamine Creates an Alternate Ligand for L-Selectin von Andre, Pascale, Spertini, Olivier, Guia, Sophie, Rihet, Pascal, Dignat-George, Francoise, Brailly, Herve, Sampol, Jose, Anderson, Paul J., Vivier, Eric

Volltext